Kevin J Pridham

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Cancer Stem Cells

Duchenne Muscular Dystrophy

Top Venues

Journal of cardiovascular development and disease

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Alison Cash, Caroline de Jager, Thomas Brickler, Eman Soliman, Liliana R Ladner, Alexandra M Kaloss, Yumeng Zhu, Kevin J Pridham, Jatia Mills, Jing Ju, Erwin Kristobal Gudenschwager Basso, Michael Chen, Zachary Johnson, Yianni Sotiropoulos, Xia Wang, Hehuang Xie, John B Matson, Eric A Marvin, Michelle H Theus
Endothelial deletion of EPH receptor A4 alters single-cell profile and Tie2/Akap12 signaling to preserve blood-brain barrier integrity. Proceedings of the National Academy of Sciences of the United States of America 120 (41) (2023)
Kevin J Pridham, Farah Shah, Kasen R Hutchings, Kevin L Sheng, Sujuan Guo, Min Liu, Pratik Kanabur, Samy Lamouille, Gabrielle Lewis, Marc Morales, Jane Jourdan, Christina L Grek, Gautam G Ghatnekar, Robin Varghese, Deborah F Kelly, Robert G Gourdie, Zhi Sheng
Connexin 43 confers chemoresistance through activating PI3K. Oncogenesis 11 (1) (2022)
Spencer R Marsh, Zachary J Williams, Kevin J Pridham, Robert G Gourdie
Correction: Marsh et al. Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine. J. Cardiovasc. Dev. Dis. 2021, 8 , 52. Journal of cardiovascular development and disease 9 (4) (2022)
Spencer R Marsh, Zachary J Williams, Kevin J Pridham, Robert G Gourdie
Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine. Journal of cardiovascular development and disease 8 (5) (2021)
Vera Cherkasova, James R Iben, Kevin J Pridham, Alan C Kessler, Richard J Maraia
The leucine-NH4+ uptake regulator Any1 limits growth as part of a general amino acid control response to loss of La protein by fission yeast. PloS one 16 (6) (2021)